Last updated: 22 July 2019 at 11:58pm EST

Kenneth H Keller Net Worth




The estimated Net Worth of Kenneth H Keller is at least $1.53 Millón dollars as of 12 February 2009. Kenneth Keller owns over 6,000 units of Surmodics stock worth over $968,981 and over the last 21 years Kenneth sold SRDX stock worth over $559,554.

Kenneth Keller SRDX stock SEC Form 4 insiders trading

Kenneth has made over 7 trades of the Surmodics stock since 2003, according to the Form 4 filled with the SEC. Most recently Kenneth exercised 6,000 units of SRDX stock worth $39,360 on 12 February 2009.

The largest trade Kenneth's ever made was exercising 10,000 units of Surmodics stock on 22 August 2007 worth over $25,000. On average, Kenneth trades about 2,625 units every 126 days since 2003. As of 12 February 2009 Kenneth still owns at least 24,700 units of Surmodics stock.

You can see the complete history of Kenneth Keller stock trades at the bottom of the page.



What's Kenneth Keller's mailing address?

Kenneth's mailing address filed with the SEC is , , , , .

Insiders trading at Surmodics

Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj y Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.



What does Surmodics do?

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.



Complete history of Kenneth Keller stock trades at Surmodics

Persona
Trans.
Transacción
 Precio total
Kenneth H Keller
Director
 Uso de opción $39,360
12 Feb 2009
Kenneth H Keller
Director
 Uso de opción $25,000
22 Aug 2007
Kenneth H Keller
Director
 Venta $102,523
16 Aug 2007
Kenneth H Keller
Director
 Venta $388,551
16 Aug 2007
Kenneth H Keller
Director
 Uso de opción $25,000
30 Jul 2007
Kenneth H Keller
Director
 Uso de opción $10,000
1 Oct 2004
Kenneth H Keller
Director
 Venta $68,480
13 Aug 2003


Surmodics executives and stock owners

Surmodics executives and other stock owners filed with the SEC include: